Viewing nowCombinationTelminuvo Tablet 40/5 mg (Telmisartan, Esamlodipine Besilate Hydrate)
Telmisartan 40mg · S-Amlodipine Besylate Dihydrate 7.38mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.

MFDS item code 201302982 · Approved 2013.01.31 · Insurance code 643306530
Treatment of essential hypertension not controlled by monotherapy
This medication is used for effectively lowering blood pressure in patients with essential hypertension whose blood pressure is not well controlled with monotherapy of telmisartan or esamlodipine (amlodipine).
The recommended dose of this medicine is 1 tablet once daily, taken with water, regardless of meals. If possible, it is recommended that it be taken at the same time each day (e.g., in the morning). Before starting this medicine, it is recommended that the doses of the individual components (telmisartan or S-amlodipine (amlodipine)) be adjusted. However, if blood pressure is not adequately controlled with an individual component, switching directly to this medicine may be considered as follows: - 40/2.5 milligrams: For patients whose blood pressure is not adequately controlled with S-amlodipine 2.5 milligrams (amlodipine 5 milligrams) or telmisartan 40 milligrams. - 80/2.5 milligrams: For patients whose blood pressure is not adequately controlled with S-amlodipine 2.5 milligrams (amlodipine 5 milligrams). - 40/5 milligrams: For patients whose blood pressure is not adequately controlled with telmisartan 40 milligrams or 80 milligrams. - 80/5 milligrams: For patients whose blood pressure is not adequately controlled with telmisartan 80 milligrams or this medicine 40/5 milligrams. Patients taking telmisartan and S-amlodipine (amlodipine) concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. ◦ Patients with renal impairment: No dose adjustment is needed for patients with mild or moderate renal impairment. For patients with severe renal impairment, however, it is recommended that treatment be started at a low dose and the dose increased gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ◦ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine dosage regimen is recommended for elderly patients, but caution should be exercised when increasing the dose (see section '3. Patients in whom this medicine should be used with caution'). For elderly patients aged 75 years or older, amlodipine clearance is reduced; therefore, treatment should be started at a low dose and the dose increased gradually.
◦ Pediatric patients: The safety and efficacy of this medicine have not been established in pediatric patients aged 18 years or younger; therefore, its use is not recommended.
This medication can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters, so it should not be taken by women who are pregnant or may become pregnant. This medication is contraindicated in patients with an allergy to the active ingredients or specific heart diseases, liver dysfunctions, and severe hypotension. Caution is required for patients with liver dysfunction, gastrointestinal diseases, kidney impairment, and the elderly when using this medication. Blood pressure may drop too low, so if symptoms of hypotension occur, the patient should lie down immediately and receive necessary treatment. This medication can increase blood potassium levels, so caution is needed when taken with potassium-rich medications or supplements. Patients with poor kidney function should regularly have blood tests to check kidney status and electrolyte levels. This medication can cause drowsiness or dizziness, so caution is required during driving or operating hazardous machinery. There may be interactions with other medications, particularly with lithium, digoxin, warfarin, and non-steroidal anti-inflammatory drugs, so consultation with a professional is advised when taken concurrently. In case of overdose, symptoms such as hypotension, arrhythmia, and renal failure may occur, requiring immediate medical attention. Safety and efficacy in children have not been adequately established, so use in this population is not recommended. This medication should be stored out of the reach of children and should not be transferred to other containers.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to avoid exposure to air and humidity. It should be kept at room temperature between 1 and 30 degrees Celsius, avoiding very hot or very cold places.
Pale yellow - egg-shaped tablet with two layers of blue color
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan 40mg · S-Amlodipine Besylate Dihydrate 7.38mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
CombinationTelmisartan 80mg · S-Amlodipine Besylate Dihydrate 3.69mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
CombinationTelmisartan 40mg · S-Amlodipine Besylate Dihydrate 3.69mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
CombinationTelmisartan 80mg · S-Amlodipine Besylate Dihydrate 7.38mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
Telmisartan 80mg · S-Amlodipine Besylate Dihydrate 7.38mg
Tablet · Prescription medication · Combination
BC World Pharmaceutical Co., Ltd.
Telmisartan 80mg · S-Amlodipine Besylate Dihydrate 7.38mg
Tablet · Prescription medication · Combination
BC World Healthcare Co., Ltd.
Telmisartan 40mg · S-Amlodipine Besylate Dihydrate 7.38mg
Tablet · Prescription medication · Combination
BC World Pharmaceutical Co., Ltd.
Telmisartan 40mg · S-Amlodipine Besylate Dihydrate 3.69mg
Tablet · Prescription medication · Combination
BC World Pharma Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.